Phase II trial of palliative radiotherapy for hepatocellular carcinoma and liver metastases

Journal of Clinical Oncology

Volumn 31, Issue 31, 2013, Pages 3980-3986

  Soliman, Hany ^a   Ringash, Jolie ^b,c   Jiang, Haiyan ^b   Singh, Kawalpreet ^c   Kim, John ^b   Dinniwell, Robert ^b   Brade, Anthony ^b   Wong, Rebecca ^b   Brierley, James ^b   Cummings, Bernard ^b   Zimmermann, Camilla ^b   Dawson, Laura A ^b  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; DEXAMETHASONE; GRANISETRON; PROCHLORPERAZINE; SUNITINIB;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BRIEF PAIN INVENTORY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; FATIGUE; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; GASTRITIS; HUMAN; LIVER CELL CARCINOMA; LIVER METASTASIS; MALE; MIDDLE AGED; NAUSEA; NAUSEA AND VOMITING; PALLIATIVE THERAPY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SYMPTOM; TREATMENT OUTCOME; TREATMENT RESPONSE; YOUNG ADULT; LIVER TUMOR; METASTASIS; METHODOLOGY; RADIOTHERAPY; VERY ELDERLY; CARCINOMA, HEPATOCELLULAR; CLINICAL TRIAL; LIVER NEOPLASMS; PROCEDURES; SECONDARY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PALLIATIVE CARE; QUALITY OF LIFE; RADIOTHERAPY; TREATMENT OUTCOME;

EID: 84891622167     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.49.9202     Document Type: Article

References (50)

1. Parkin DM, Bray F, Ferlay J, et al: Global cancer statistics, 2002. CA Cancer J Clin 55:74-108, 2005 (Pubitemid 40372904)
2. Zhu AX: Hepatocellular carcinoma: Are we making progress? Cancer Invest 21:418-428, 2003
3. Ho S, Lau WY, Leung TW, et al: Internal radiation therapy for patients with primary or metastatic hepatic cancer: A review. Cancer 83:1894-1907, 1998 (Pubitemid 28503720)
4. Tanaka N, Matsuzaki Y, Chuganji Y, et al: Proton irradiation for hepatocellular carcinoma. Lancet 340:1358, 1992
5. Matsuura M, Nakajima N, Arai K, et al: The usefulness of radiation therapy for hepatocellular carcinoma. Hepatogastroenterology 45:791-796, 1998 (Pubitemid 28321060)
6. Seong J, Park HC, Han KH, et al: Local radiotherapy for unresectable hepatocellular carcinoma patients who failed with transcatheter arterial chemoembolization. Int J Radiat Oncol Biol Phys 47: 1331-1335, 2000 (Pubitemid 30421186)
7. Dawson LA, McGinn CJ, Normolle D, et al: Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. J Clin Oncol 18:2210-2218, 2000 (Pubitemid 30350212)
8. Lee MT, Kim JJ, Dinniwell R, et al: Phase I study of individualized stereotactic body radiotherapy of liver metastases. J Clin Oncol 27:1585-1591, 2009
9. Dawson LA, Normolle D, Balter JM, et al: Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys 53:810-821, 2002 (Pubitemid 34722625)
10. Pan CC, Kavanagh BD, Dawson LA, et al: Radiation-associated liver injury. Int J Radiat Oncol Biol Phys 76:S94-S100, 2010 (suppl)
11. Seong J, Keum KC, Han KH, et al: Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 43:393-397, 1999 (Pubitemid 29091482)
12. Wulf J, Hädinger U, Oppitz U, et al: Stereotactic radiotherapy of targets in the lung and liver. Strahlenther Onkol 177:645-655, 2001 (Pubitemid 34015341)
13. Méndez RA, Wunderink W, Hussain SM, et al: Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase I-II study. Acta Oncol 45:831-837, 2006 (Pubitemid 44423129)
14. Blomgren H, Lax I, Goranson H, et al: Radiosurgery for tumors in the body: Clinical experience using a new method. J Radiosurg 1:63-74, 1998
15. Hoyer M, Roed H, Traberg Hansen A, et al: Phase II study on stereotactic body radiotherapy of colorectal metastases. Acta Oncol 45:823-830, 2006 (Pubitemid 44423128)
16. Wada H, Takai Y, Nemoto K, et al: Univariate analysis of factors correlated with tumor control probability of three-dimensional conformal hypofractionated high-dose radiotherapy for small pulmonary or hepatic tumors. Int J Radiat Oncol Biol Phys 58:1114-1120, 2004 (Pubitemid 38314793)
17. Herfarth KK, Debus J, Lohr F, et al: Stereotactic single-dose radiation therapy of liver tumors: Results of a phase I/II trial. J Clin Oncol 19:164-170, 2001 (Pubitemid 32063493)
18. Herfarth KK, Hof H, Bahner ML, et al: Assessment of focal liver reaction by multiphasic CT after stereotactic single-dose radiotherapy of liver tumors. Int J Radiat Oncol Biol Phys 57:444-451, 2003 (Pubitemid 37040941)
19. Ingold JA, Reed GB, Kaplan HS, et al: Radiation hepatitis. Am J Roentgenol Radium Ther Nucl Med 93:200-208, 1965
20. Wharton JT, Delclos L, Gallager S, et al: Radiation hepatitis induced by abdominal irradiation with the cobalt 60 moving strip technique. Am J Roentgenol Radium Ther Nucl Med 117:73-80, 1973
21. Sherman DM, Weichselbaum R, Order SE, et al: Palliation of hepatic metastasis. Cancer 41:2013-2017, 1978 (Pubitemid 8348557)
22. Borgelt BB, Gelber R, Brady LW, et al: The palliation of hepatic metastases: Results of the Radiation Therapy Oncology Group pilot study. Int J Radiat Oncol Biol Phys 7:587-591, 1981 (Pubitemid 11072538)
23. Prasad B, Lee MS, Hendrickson FR: Irradiation of hepatic metastases. Int J Radiat Oncol Biol Phys 2:129-132, 1977 (Pubitemid 8086043)
24. Turek-Maischeider M, Kazem I: Palliative irradiation for liver metastases. JAMA 232:625-628, 1975
25. Leibel SA, Pajak TF, Massullo V, et al: A comparison of misonidazole sensitized radiation therapy to radiation therapy alone for the palliation of hepatic metastases: Results of a Radiation Therapy Oncology Group randomized prospective trial. Int J Radiat Oncol Biol Phys 13:1057-1064, 1987 (Pubitemid 17106936)
26. Bydder S, Spry NA, Christie DR, et al: A prospective trial of short-fractionation radiotherapy for the palliation of liver metastases. Australas Radiol 47:284-288, 2003 (Pubitemid 37127902)
27. Chow E, Harris K, Fan G, et al: Palliative radiotherapy trial for bone metastases: A systematic review. J Clin Oncol 25:1423-1436, 2007 (Pubitemid 46706892)
28. Cleeland CS, Ryan KM: Pain assessment: Global use of the Brief Pain Inventory. Ann Acad Med Singapore 23:129-138, 1994
29. Aaronson NK, Ahmedzai S, Bergman B, et al: The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365-376, 1993 (Pubitemid 23073154)
30. Heffernan N, Cella D, Webster K, et al: Measuring health-related quality of life in patients with hepatobiliary cancers: The Functional Assessment of Cancer Therapy-Hepatobiliary questionnaire. J Clin Oncol 20:2229-2239, 2002 (Pubitemid 34441650)
31. Cella DF, Tulsky DS, Gray G, et al: The Functional Assessment of Cancer Therapy scale: Development and validation of the general measure. J Clin Oncol 11:570-579, 1993 (Pubitemid 23071057)
32. National Cancer Institute: National Cancer Institute Common Toxicity Criteria (CTC) version 2. http://ctep.cancer.gov/protocolDevelopment/electronic- applications/docs/ctcv20-4-30-992.pdf
33. Chow E, Wu JS, Hoskin P, et al: International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Radiother Oncol 64:275-280, 2002 (Pubitemid 35254020)
34. Osoba D, Rodrigues G, Myles J, et al: Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16:139-144, 1998 (Pubitemid 28041591)
35. Ringash J, O'Sullivan B, Bezjak A, et al: Interpreting clinically significant changes in patient-reported outcomes. Cancer 110:196-202, 2007 (Pubitemid 46986433)
36. Rinck GC, van den Bos GA, Kleijnen J, et al: Methodologic issues in effectiveness research on palliative cancer care: A systematic review. J Clin Oncol 15:1697-1707, 1997 (Pubitemid 27167411)
37. Blazeby JM, Fayers P, Conroy T, et al: Validation of the European Organization for Research and Treatment of Cancer QLQ-LMC21 questionnaire for assessment of patient-reported outcomes during treatment of colorectal liver metastases. Br J Surg 96:291-298, 2009
38. Steel JL, Chopra K, Olek MC, et al: Health-related quality of life: Hepatocellular carcinoma, chronic liver disease, and the general population. Qual Life Res 16:203-215, 2007 (Pubitemid 46088354)
39. Lai HL, Lin SY, Yeh SH. Exploring uncertainty, quality of life and related factors in patients with liver cancer. Hu Li Za Zhi 54:41-52, 2007
40. Kondo Y, Yoshida H, Tateishi R, et al: Health-related quality of life of chronic liver disease patients with and without hepatocellular carcinoma. J Gastroenterol Hepatol 22:197-203, 2007 (Pubitemid 46181349)
41. Shun SC, Chiou JF, Lai YH, et al: Changes in quality of life and its related factors in liver cancer patients receiving stereotactic radiation therapy. Support Care Cancer 16:1059-1065, 2008
42. Fan SY, Eiser C, Ho MC: Health-related quality of life in patients with hepatocellular carcinoma: A systematic review. Clin Gastroenterol Hepatol 8:559-564, 2010
43. Wang YB, Chen MH, Yan K, et al: Quality of life of primary hepatocellular carcinoma patients after radiofrequency ablation. Ai Zheng 24:827-833, 2005
44. Chen L, Liu Y, Li GG, et al: Quality of life in patients with liver cancer after operation: A 2-year follow-up study. Hepatobiliary Pancreat Dis Int 3:530-533, 2004 (Pubitemid 39561961)
45. Wang YB, Chen MH, Yan K, et al: Quality of life after radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma: Comparison with transcatheter arterial chemoembolization alone. Qual Life Res 16:389-397, 2007 (Pubitemid 46363693)
46. Ueno S, Tanabe G, Nuruki K, et al: Quality of life after hepatectomy in patients with hepatocellular carcinoma: Implication of change in hepatic protein synthesis. Hepatogastroenterology 49:492-496, 2002 (Pubitemid 34606580)
47. Reference deleted
48. Glare P, Virik K, Jones M, et al: A systematic review of physicians' survival predictions in terminally ill cancer patients. BMJ 327:195-198, 2003 (Pubitemid 36920584)
49. Bruera E, Kuehn N, Miller MJ, et al: The Edmonton Symptom Assessment System (ESAS): A simple method for the assessment of palliative care patients. J Palliat Care 7:6-9, 1991
50. Cleeland CS, Mendoza TR, Wang XS, et al: Assessing symptom distress in cancer patients: The M.D. Anderson Symptom Inventory. Cancer 89: 1634-1646, 2000